RECCHIA, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.839
EU - Europa 4.670
AS - Asia 4.575
SA - Sud America 675
AF - Africa 106
OC - Oceania 57
Continente sconosciuto - Info sul continente non disponibili 4
Totale 20.926
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.614
IT - Italia 1.458
SG - Singapore 1.435
GB - Regno Unito 1.165
CN - Cina 1.152
VN - Vietnam 520
HK - Hong Kong 512
BR - Brasile 504
SE - Svezia 501
DE - Germania 356
FR - Francia 219
BD - Bangladesh 212
RU - Federazione Russa 203
FI - Finlandia 170
UA - Ucraina 166
TR - Turchia 113
CA - Canada 108
KR - Corea 106
IN - India 99
ID - Indonesia 82
NL - Olanda 82
JP - Giappone 65
BG - Bulgaria 60
MX - Messico 59
AR - Argentina 57
BE - Belgio 51
IQ - Iraq 48
AU - Australia 47
ZA - Sudafrica 44
AE - Emirati Arabi Uniti 34
IE - Irlanda 32
LT - Lituania 31
BZ - Belize 28
CO - Colombia 26
ES - Italia 26
PK - Pakistan 26
EC - Ecuador 22
VE - Venezuela 21
MY - Malesia 20
PL - Polonia 20
AT - Austria 19
IR - Iran 19
CH - Svizzera 16
CL - Cile 16
CZ - Repubblica Ceca 16
JO - Giordania 16
PH - Filippine 16
SA - Arabia Saudita 16
MA - Marocco 15
UZ - Uzbekistan 12
NP - Nepal 11
AL - Albania 10
NZ - Nuova Zelanda 10
TN - Tunisia 10
PT - Portogallo 9
SI - Slovenia 9
LU - Lussemburgo 8
PE - Perù 8
RO - Romania 8
TH - Thailandia 8
BO - Bolivia 7
DZ - Algeria 7
EG - Egitto 7
KE - Kenya 7
PY - Paraguay 7
RS - Serbia 7
GR - Grecia 6
TW - Taiwan 6
UY - Uruguay 6
AZ - Azerbaigian 5
BY - Bielorussia 5
DO - Repubblica Dominicana 5
IL - Israele 5
PS - Palestinian Territory 5
CR - Costa Rica 4
ET - Etiopia 4
KZ - Kazakistan 4
NG - Nigeria 4
OM - Oman 4
PA - Panama 4
QA - Qatar 4
TT - Trinidad e Tobago 4
DK - Danimarca 3
EU - Europa 3
GE - Georgia 3
JM - Giamaica 3
KG - Kirghizistan 3
LB - Libano 3
LK - Sri Lanka 3
NO - Norvegia 3
PR - Porto Rico 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BW - Botswana 2
CY - Cipro 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
LV - Lettonia 2
MD - Moldavia 2
Totale 20.908
Salva come PNG Salva come JPEG
Città #
Fairfield 1.041
Ashburn 1.034
Singapore 976
Santa Clara 927
Southend 746
Chandler 598
Woodbridge 586
Houston 499
Hong Kong 489
San Jose 470
Seattle 384
Cambridge 362
Ann Arbor 336
Wilmington 318
Jacksonville 301
Dearborn 279
Nyköping 274
Hefei 262
Beijing 241
Modena 212
Los Angeles 206
Council Bluffs 194
London 186
Chicago 182
New York 148
Ho Chi Minh City 142
Bologna 126
Helsinki 125
Hanoi 120
The Dalles 104
San Diego 101
Seoul 91
Milan 78
Buffalo 74
Princeton 73
Moscow 64
Jakarta 63
Salt Lake City 63
Lauterbourg 59
Sofia 59
Bremen 55
Eugene 52
Brussels 49
Izmir 48
Shanghai 48
Dallas 45
Rome 43
Elk Grove Village 40
Orem 40
Munich 39
São Paulo 39
Frankfurt am Main 36
Toronto 35
Tampa 33
Columbus 32
Da Nang 32
Redwood City 32
Des Moines 30
Falls Church 30
Phoenix 29
Belize City 28
San Francisco 28
Parma 27
Tokyo 27
Dong Ket 25
Dublin 25
Haiphong 25
Paris 24
Boardman 23
Brooklyn 23
Mexico City 22
Bari 21
Atlanta 20
Las Vegas 20
Montreal 20
Rio de Janeiro 20
Mumbai 19
Baghdad 18
Boston 18
Amsterdam 17
Chennai 17
Johannesburg 17
Lancaster 17
Naples 17
Denver 16
Turin 16
Warsaw 16
Guangzhou 15
Nuremberg 15
Sterling 15
Stockholm 15
Trieste 15
Biên Hòa 14
Poplar 14
Wuhan 14
Albuquerque 13
Fremont 13
Nanjing 13
Portsmouth 13
Reggio Emilia 13
Totale 14.128
Salva come PNG Salva come JPEG
Nome #
Closure of a Large Chronic Wound through Transplantation of Gene-Corrected Epidermal Stem Cells 578
In vivo editing of the human mutant Rhodopsin gene by electroporation of plasmid-based CRISPR/Cas9 in the mouse retina 450
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells 430
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 423
CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient 422
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 421
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 419
IL-7 and IL-15 instruct the generation of human memory stem T cells from naïve precursors 417
CRISPR/Cas9-mediated specific knock-down of dominant mutations in Rhodopsin gene 410
Transcription factor binding sites are genetic determinants of retroviral integration in the human genome. 401
Targeted Gene Addition in Human Epithelial Stem Cells by Zinc-finger Nuclease-mediated Homologous Recombination 393
Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa. 381
Correction of recessive dystrophic epidermolysis bullosa by transposon-mediated integration of COL7A1 in transplantable patient-derived primary keratinocytes. 376
Transcriptionally regulated and nontoxic delivery of the hyperactive Sleeping Beauty Transposase 368
Transcriptionally regulated and non-toxic delivery of the hyperactive Sleeping Beauty Transposase 363
CRISPR/Cas9 gene editing in vitro and in retinal cells in vivo 362
Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer Progression 361
Comprehensive genomic access to vector integration in clinical gene therapy 358
Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells 357
Targeted gene integration in human epidermal stem cells by Zinc-finger nuclease-mediated homologous recombination. 340
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 336
Nuclear architecture dictates HIV-1 integration site selection 334
Site-specific integration by the adeno-associated virus rep protein 328
Genomic Analysis of Sleeping Beauty Transposon Integration in Human Somatic Cells 327
Long-Term Skin Regeneration From a Gene-Targeted Human Epidermal Stem Cell Clone 323
A single epidermal stem cell strategy for safe ex vivo gene therapy 321
Hot spots of retroviral integrations in human CD34+ hematopoietic cells 318
Development of a Sleeping Beauty transposon-based integration system for gene transfer in human epithelial cells 315
Design of a regulated lentiviral vector for hematopoietic stem cell gene therapy of globoid cell leukodystrophy 312
Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates. 308
AAV-CRISPR Persistence in the Eye of the Beholder 307
High-definition mapping of retroviral integration sites defines the fate of allogeneic T cells after donor lymphocyte infusion. 298
Site-specific integration into the human genome: Ready for clinical application? 292
In vitro and in vivo genome editing of the RHO gene to downregulate dominant mutations 292
In vitro and in vivo CRISPR/Cas9-mediated genome editing to downregulate dominant mutations in Rhodopsin gene 292
Tracking gene-modified T cells in vivo. 289
An efficient in vitro transposition method by a transcriptionally regulated sleeping beauty system packaged into an integration defective lentiviral vector 282
Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design 275
Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors 274
Genotoxic signature in cord blood cells of newborns exposed in utero to a zidovudine-based antiretroviral combination 273
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 273
Collagen VII gene delivery via Sleeping Beauty transposon in COL7A1-deficient keratinocytes from epidermolysis bullosa patients 272
Defining the lentiviral integrome in human hematopoietic cells 266
Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector 256
Non viral gene transfer via Sleeping beauty transposon for Collagen VII delivery in human primary keratinocytes. 253
CRISPR-mediated T cell engineering against Non-Small Cell Lung Cancer 250
Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model 247
Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells 246
Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector 244
Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER 241
CRISPR/Cas9 Allele-Specific Design To Inactivate A Dominant-Negative Mutation In COL6A1 Causing Ullrich Muscular Dystrophy 234
Relative influence of the adeno-associated virus (AAV) type 2 p5 element for recombinant AAV vector site-specific integration 232
Beta1 integrin activates Rac1 in Schwann cells to generate radial lamellae during axonal sorting and myelination 232
Gene editing prospects for treating inherited retinal diseases 222
Engineered Sleeping Beauty Transposon as Efficient System to Optimize Chimp Adenoviral Production 221
Targeted integration of a large transgene cassette by TALEN and ZFN-mediated homologous recombination. 220
Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy 219
IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis 212
Transcriptional and epigenetic analyses of the DMD locus reveal novel cisâ acting DNA elements that govern muscle dystrophin expression 203
CRISPR-Mediated Genome Editing to Redirect T Cells against Non-Small Cell Lung Cancer 182
Erratum: Genomic analysis of sleeping beauty transposon integration in human somatic cells (PLoS ONE (2014) 9:11 (e112712) DOI: 10.1371/journal.pone.0112712) 181
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 173
Corrigendum to: “Transcriptional and epigenetic analyses of the DMD locus reveal novel cis-acting DNA elements that govern muscle dystrophin expression”. [Biochim. Biophys. Acta Gene Regul. Mech. 2017 Nov;1860(11):1138–1147.] (Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2017) 1860(11) (1138–1147), (S1874939917301359), (10.1016/j.bbagrm.2017.08.010)) 166
Efficient CRISPR/Cas9-Mediated iIn Situ Correction of LAMB3 Gene in Keratinocytes Derived from Junctional Epidermolysis Bullosa Patient 166
CRISPR/Cas9 allele-specifc design to inactivate a dominant-negative mutation in COL6A1 causing Ullrich muscular dystrophy. 161
In vitro and in vivo genome editing of the RHO gene to downregulate dominant mutations 160
Collagen VII gene delivery via an Adeno-Sleeping Beauty transposon in COL7A1-deficient keratinocytes from epidermolysis bullosa patients 157
Specific Knock-down of P347S Dominant Mutation in Rhodopsin Gene by CRISPR/Cas9 System 154
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 151
The Journal of Gene Medicine European Society of Gene Therapy Young Investigator Award 2004 144
Induced Pluripotent Stem Cells and Genome-Editing Tools in Determining Gene Function and Therapy for Inherited Retinal Disorders 141
TALEN-mediated in situ correction of a genetic defect by homologous recombination into the native locus 139
Specific knock-down of C-terminal dominant mutation in Rhodopsin gene by CRISPR/Cas9 system 136
Engineered nucleases-mediated in situ correction of a genetic defect by homologous recombination into the native locus 135
Restored Collagen VI Microfilaments Network in the Extracellular Matrix of CRISPR-Edited Ullrich Congenital Muscular Dystrophy Fibroblasts 130
Profibrotic Molecules Are Reduced in CRISPR-Edited Emery–Dreifuss Muscular Dystrophy Fibroblasts 52
Totale 21.197
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.193
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021114 0 0 0 0 0 0 0 0 0 0 0 114
2021/20221.756 77 173 208 102 113 101 132 123 145 112 279 191
2022/20231.921 211 207 165 218 243 257 50 160 207 25 96 82
2023/20241.186 53 72 93 99 217 70 113 147 28 84 83 127
2024/20253.502 105 46 131 229 664 517 274 251 355 184 341 405
2025/20266.620 419 221 428 737 1.242 425 755 258 674 641 473 347
Totale 21.197